Brighton Jones’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Other funds holding SRPT
Brighton Jones's SRPT Position: Q3 2026 in Review
Brighton Jones sold out of Sarepta Therapeutics (SRPT) in Q3 2026, closing a stake of 19,491 shares — an estimated $350K sold.
Brighton Jones first reported a position in SRPT in Q3 2017 and held it in 6 quarters. The position peaked at $718K in Q1 2026. 253 funds tracked by Wall St. Rank hold SRPT as of Q3 2026.
- Brighton Jones reported no remaining Sarepta Therapeutics position as of Q3 2026 after selling out during the quarter.
- Brighton Jones sold 19,491 Sarepta Therapeutics shares in Q3 2026, an estimated $350K.
- Brighton Jones first reported a position in Sarepta Therapeutics in Q3 2017 and held it in 6 quarters.
- Brighton Jones's Sarepta Therapeutics position peaked at $718K in Q1 2026.
- 253 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.